XML 55 R13.htm IDEA: XBRL DOCUMENT
v3.25.1

INVESTMENTS | 3 Months Ended
--- | ---
Mar. 31, 2025
Investments in and Advances to Affiliates [Abstract] |
INVESTMENTS | 5. INVESTMENTS The following table summarizes the Company’s investments:
| As of |  | Percentage of total investments as of
| March 31, |  | December 31, |  | March 31, |  | December 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Equity method investments: |  |  |  |  |  |  |
Equity method - carried interest | $ | 3,557,277 |  |  | $ | 3,495,115 |  |  | 72.7% |  | 75.2%
Equity method private investment partnership interests - principal | 604,691 |  |  | 536,912 |  |  | 12.4 |  | 11.6
Equity method private investment partnership interests and other (held at fair value) | 426,613 |  |  | 411,417 |  |  | 8.7 |  | 8.9
Equity method private investment partnership interests and other | 66,896 |  |  | 55,461 |  |  | 1.4 |  | 1.2
Total equity method investments | 4,655,477 |  |  | 4,498,905 |  |  | 95.2 |  | 96.9
Collateralized loan obligations | 18,492 |  |  | 19,040 |  |  | 0.4 |  | 0.4
Fixed income securities | 170 |  |  | 22,793 |  |  | — |  | 0.5
Collateralized loan obligations and fixed income securities, at fair value | 18,662 |  |  | 41,833 |  |  | 0.4 |  | 0.9
Common stock, at fair value | 218,150 |  |  | 104,037 |  |  | 4.5 |  | 2.2
Total investments | $ | 4,892,289 |  |  | $ | 4,644,775 |  |  |  |  |
Equity Method Investments The Company’s equity method investments include investments that are not consolidated but over which the Company exerts significant influence. The Company evaluates each of its equity method investments to determine if any were significant as defined by guidance from the SEC. As of and for the three months ended March 31, 2025 and 2024, no individual equity method investment held by the Company met the significance criteria. The following table presents the Company’s share of other income, net from its equity method investments, which were included within principal investment income, net realized and unrealized gains on investments, and interest and dividend income within the Condensed Consolidated Statements of Operations:
|  |  |  | Three months ended March 31,
|  |  |  |  |  | 2025 |  | 2024 |  |
Total other income, net related to equity method investments |  |  |  |  |  | $ | 30,964 |  |  | $ | 10,127 |  |  |
With respect to the Company’s equity method investments, the material assets are expected to generate either long term capital appreciation and/or interest income, the material liabilities are debt instruments collateralized by, or related to, the financing of the assets and net income is materially comprised of the changes in fair value of these net assets. Equity Method Investments Held at Fair Value The following table summarizes the changes in fair value of the Company’s equity method investments held at fair value, which are included within net realized and unrealized gains on investments within the Condensed Consolidated Statements of Operations:
|  |  | Three months ended March 31,
|  |  |  |  | 2025 |  | 2024 |  |
Equity method private investment partnership interests and other (held at fair value) |  |  |  |  | $ | 4,281 |  |  | $ | 2,479 |  |  |
Investments of the Consolidated Funds The following table summarizes investments held in the Consolidated Funds:
| Fair Value as of |  | Percentage of total investments as of
| March 31, |  | December 31, |  | March 31, |  | December 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Fixed income investments: |  |  |  |  |  |  |
Loans and securitization vehicles | $ | 6,880,718 |  |  | $ | 7,907,449 |  |  | 57.4% |  | 62.1%
Money market funds and U.S. treasury securities | 556,498 |  |  | 550,800 |  |  | 4.6 |  | 4.3
Bonds | 344,140 |  |  | 418,069 |  |  | 2.9 |  | 3.3
Total fixed income investments | 7,781,356 |  |  | 8,876,318 |  |  | 64.9 |  | 69.7
Partnership interests | 2,318,557 |  |  | 2,000,380 |  |  | 19.4 |  | 15.7
Equity securities | 1,876,393 |  |  | 1,861,146 |  |  | 15.7 |  | 14.6
Total investments, at fair value | $ | 11,976,306 |  |  | $ | 12,737,844 |  |  |  |  |
As of March 31, 2025 and December 31, 2024, no single issuer or investment, including derivative instruments and underlying portfolio investments of the Consolidated Funds, had a fair value that exceeded 5.0% of the Company’s total assets.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration